Aegis's Clinical Update Webinar
Register for Aegis's Clinical Update Webinar
Expansion of Urine Behavioral Health Drug Testing, AcuRiseID™
[Duration: 15 minutes]
- Medication non-adherence in the behavioral health population increases the risk of relapse, hospitalization, and overall costs.
- Urine behavioral health drug testing is now offered for over 100 medications and illicit drugs, designed for mental health and recovery care providers' unique needs.
- AcuRiseID™ is an objective medication monitoring tool for measuring treatment adherence and potential substance use.
- Medication adherence improves symptoms and quality of life in behavioral health patients.
Hina Patel, Pharm.D., MBA, BCGP
Aegis Sciences Corporation
Thursday, February 25, 2021
10:00 AM Central
1:00 PM Central
Choose from two live presentation times. Click the register button on the WebEx page to complete the form. The meeting link will be emailed to you upon registration.